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95% CI 0.84-1.42) variants failed to reach statistical significance. In contrast,
the distribution of the 4a4b genotype differed significantly between MI patients
and controls (²= 9.82, p=0.007). Allele 4a was significantly more frequent in
MI patients than in controls (p=0.0007, OR=1.76, 95% CI 1.25-2.49).
Conclusion: The present study demonstrates that 4a4b polymorphism but
not 894G>T and –786T>C is associated with MI in the Tunisian population. 
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Aims: Myocardial infarction (MI) is a disease with multifactorial back-
ground. Inflammation is involved in the pathophysiology of atherosclerosis
and its clinical complications, such as MI. Several proinflammatory molecules
have been identified in atherosclerotic lesions. Chemokines and their receptors
seem to play a pivotal role in the genesis and progression of atherosclerosis.
Two of these are CCR2 and CCR5 that bind MCP-1, macrophage inflamma-
tory proteins-1 (MIP-1)  or MIP-1 respectively. Several polymorphisms in
the CCR2 and CCR5 genes appear to play a role in MI. Conflicting results
have been reported regarding the effect of these polymorphisms on MI. The
aim of our study was to examine both the association between CCR2 (CCR2-
64I), CCR5 (CCR532) variants and the estimation of haplotypes with Myo-
cardial Infarction in Tunisian population.
Methods: This study included 572 unrelated Tunisians divided into 290
MI patients and 282 healthy controls. CCR532 and CCR2-64I polymor-
phisms were carried out by PCR-RFLP.
Results: The frequency of CCR532 allele was 0.10 in MI patients and
0.18 in controls. Genotypes were distributed as follows: 236 (w/w) (81.4%)
and 54 (w/t) (18.6%) in MI; 178 (w/w) (63.1%) and 104 (w/t) (36.9%). No
32/32 genotype was detected among tested population. The frequency of
the CCR2-64I was 0.16 and 0.14 in MI patients and controls respectively. The
frequencies were in accordance with Hardy-Weinberg equilibrium. The
CCR532 allele was underrepresented in MI patients and over-represented in
controls (p<0.001). CCR2-CCR5 haplotypes were not associated with risk of
MI.
Conclusion: Our work suggests that the genetic variation at the CCR2 and
CCR5 genes did not contribute to the risk of MI, but CCR5 polymorphism
could modulate the risk of MI in Tunisian population. 
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We aimed to determine the short and long-term effects of Serca2, Pln,
Hax1, cleaved caspase-3, Bax, and Bcl2 protein levels in early post-
ischemia/reperfusion cardiac injury and late remodeling after acute myo-
cardial infarction (MI). Male Wistar rats underwent left coronary artery
ligation and left to recover for 48 hours, 2 weeks and 8 months post-sur-
gery. Sham-operated animals served as controls. Congestive heart failure
(CHF) at 8 months was defined by increase in lung and right ventricular
weight and a drop in ejection fraction. At 48-hours after MI, an acute
increase of Serca2 (29%) expression was observed with unchanged Pln
levels. An increase of Hax1 (68%) levels was seen, which could promote
the formation of Pln monomers, the active inhibitory units of Serca2. Hax1
overexpression was found to affect apoptosis as measured by activated
cleaved caspase-3 and Bax/Bcl2 ratio levels. Two weeks post MI, although
Serca2, Hax1 and Pln levels were at Sham levels but the apoptosis markers
were reduced by 35%. By 8-months post surgery, some of the animals
developed CHF. The expression levels of the proteins tested were exam-
ined in the border (BR) and remote (RM) areas from the infarct region.
Serca2 protein levels were reduced by 50% in both BR and RM CHF tis-
sues, while in non CHF Serca2 did not change. Hax1 was 30% lower in
all MI cardiac RM segments but not in BR. Pln was not significantly
altered. Cleaved caspase-3 protein levels were higher in CHF and non-
CHF RM segments, while the Bax/Bcl2 ratio was increased in all samples,
indicating stronger intrinsic apoptotic pathway triggering. In conclusion,
an early increase of Serca2 may reflect the need for improve SR Ca-trans-
port after MI but Hax1 overexpression may be compensatory to rescue
cells from apoptosis. In long-term, apoptosis is increased controlling by
intrinsic signaling in BR, while Serca2 downregulation is the hallmark of
CHF progression.
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Pharmacologic treatments which aim to induce physiological hypertrophy
are now thought as novel treatments for heart failure. Thus, clenbuterol, a
beta-2 adrenergic agonist has recently been shown to partially reverse cardiac
remodeling by inducing physiological hypertrophy. The present study further
investigated potential underlying mechanisms of this effect in a neonatal car-
diomyocytes cell based model.
Neonatal cardiomyocytes obtained from newborn rats were exposed to
clenbuterol (CLEN, 1μ) for 5 days, while untreated cells served as con-
trols. CLEN administration resulted in well organized and orientation of
cytoskeletal fibers manifesting as a longitudinal cell shape, while had no
effect on myosin heavy chain (MHC) isoform expression. CLEN increased
cell growth as indicated by protein content: total protein per cell (pg/cell)
was 116 (6.0) for CLEN and 77 (5.0) for the untreated cells, p<0.05. This
response was accompanied by a 2.2 fold increase in phospho-p38 MAPK
levels as compared to untreated cells, p<0.05 while no changes were
observed in ERK, JNK and Akt. Administration of SB203580 (a specific
p38 MAPK inhibitor) abrogated the CLEN induced changes in cardiomy-
ocyte morphology, while it had no effect on protein content. In conclusion,
clenbuterol induces favorable changes in neonatal cardiomyocyte shape,
geometry and growth without affecting MHC isoform expression. Activa-
tion of p38 MAPK signaling seems, at least in part, to be implicated in this
response.
Changes in SR calcium transport and cell survival in post-ischemic cardiac 
remodeling
